Skip to content

Prime Minister meets with Calculus investee company, Arcis Biotechnology

Calculus Capital has welcomed the government’s pledge to boost Britain’s expanding life sciences and technology industries after the Prime Minister met the Chief Scientist behind one of its investee companies during a landmark visit to the North West. Theresa May used the visit to the Northern Powerhouse, where she held her first Cabinet meeting outside … Continued

Scancell announces collaboration with leading US lung cancer foundation

Scancell Holdings Plc  has inked a US collaboration deal with a leading lung cancer foundation that will accelerate the development of a ground-breaking immuno-oncology drug. It is teaming up with the Addario Lung Cancer Medical Institute (ALCMI) and the Bonnie J Addario Lung Cancer Foundation to take its SCIB2 cancer vaccine in phase I/II clinical trials. … Continued

Genedrive scores US army coup with DNA-testing deal

UK group to supply kits to detect biological warfare agents The FT reports that Genedrive has clinched a rare deal with the US armed forces, providing them with millions of pounds of kit to test for biological warfare agents. The US Department of Defense has now begun field trials of DNA analysis equipment from Genedrive. … Continued

John Glencross: What lies behind the rise in tax-efficient investment levels?

EIS and VCTs increasingly on investors’ radar John Glencross, Chief Executive, Calculus Capital looks at the reasons – most notably the scaling back of pension tax relief over recent years – why EIS and VCTs are appearing on the radar of an increasing number of investors Pensions are not what they used to be; certainly … Continued

Calculus Capital invests £3m in Origin Broadband

Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in Origin Broadband, an award-winning provider of internet and phone services. Since launch in 2011, Origin has developed its own infrastructure and now has the sixth largest broadband network in the UK based on ‘premises passed’. … Continued

Calculus Capital invests £3m in Weedingtech

Calculus Capital has invested £3m in cleantech firm Weedingtech, which is focused on replacing toxic herbicides. Weedingtech is a world leader in herbicide-free weed and moss control, and has earned multiple awards for sustainable innovation. The company was co-founded by environmental campaigner and entrepreneur Ben Goldsmith. Calculus has invested in the business in recognition of … Continued

Synpromics announces a research collaboration with GE Healthcare

Calculus Capital’s portfolio company Synpromics, the leading synthetic promoter and gene control company, announced a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will develop a complex bar-coded library of synthetic promoters, using its proprietary PromPT™ platform, for extensive screening in GE Healthcare’s Chinese … Continued